Inhibition by Alkylamines of NADPH Oxidase Through Blocking the Assembly of Enzyme Components
スポンサーリンク
概要
- 論文の詳細を見る
Alkylamines inhibit NADPH oxidase both in intact neutrophils and in a cell-free system. The aim of this study was to examine the mechanism underlying this inhibitory effect. Among alkylamines with different chain lengths, the C12 compound (laurylamine) showed the greatest inhibitory effect on the cell-free NADPH oxidase activity induced by arachidonic acid (AA) in the presence of GTPγS. The inhibition was overcome by further addition of AA, and it was observed irrespective of whether laurylamine was added before or after the enzyme activation by AA. When added prior to the enzyme activation, laurylamine blocked translocation to the membrane of all three cytosolic components (p47-phox, p67-phox and rac) in a cell-free translocation assay. When added after the activation, laurylamine released only rac from the membrane. Laurylamine did not inhibit the reduction of cytochrome c by xanthine oxidase, suggesting that it does not have superoxide-scavenging activity. These results indicate that laurylamine inhibits both the activation process of NADPH oxidase and the activated enzyme itself by blocking the assembly of the oxidase components.
- 社団法人 日本薬理学会の論文
著者
-
NUNOI Hiroyuki
Department of Pediatrics, Miyazaki University School of Medicine
-
Asada Makoto
Department Of Drug Discovery Eisai Tsukuba Research Laboratories
-
Nunoi Hiroyuki
Department Of Pediatrics Kumamoto University School Of Medicine
-
SAWAI Tohru
Department of Drug Discovery, Eisai Tsukuba Research Laboratories
-
NISHIZAWA Yukio
Department of Drug Discovery, Eisai Tsukuba Research Laboratories
-
KATAYAMA Kouichi
Department of Drug Discovery, Eisai Tsukuba Research Laboratories
-
Sawai Tohru
Department Of Drug Discovery Eisai Tsukuba Research Laboratories
-
Katayama K
Department Of Drug Discovery Eisai Tsukuba Research Laboratories
-
Nishizawa Y
Department Of Drug Discovery Eisai Tsukuba Research Laboratories
関連論文
- Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation
- Hazards of early BCG vaccination : BCGitis in a patient with chronic granulomatous disease
- A novel mutation of the PHKA2 gene in a patient with X-linked liver glycogenosis type 1
- Inhibition by Alkylamines of NADPH Oxidase Through Blocking the Assembly of Enzyme Components
- Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy
- Duplication (22)(q11.22-q11.23) without coloboma and cleft lip or palate
- Neutrophik Cytoskeletal Disease
- Prevalence of Inherited Myeloperoxidase Deficiency in Japan
- Successful bone marrow transplantation in chronic granulomatous disease
- Adult Onset X-Linked Chronic Granulomatous Disease in a Woman Patient Caused by a de novo Mutation in Paternal-Origin CYBB Gene and Skewed Inactivation of Normal Maternal X Chromosome
- Outcome of ANCA-Associated Primary Renal Vasculitis in Miyazaki Prefecture